SHANGHAI PHARMACEUTICALS HOLDINGS CO., LTD. (SHPMY)
Clinical trial NCT06535412 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-06-10 → 2028-12-17 3. primary completion date: 2025-12-10 → 2028-12-17
Clinical trial NCT06535412 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. completion date: 2026-06-10 → 2028-12-17 3. primary completion date: 2025-12-10 → 2028-12-17
📉 **NEGATIVE** • Medium confidence analysis (63%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (24%) **Content type:** Clinical